HealthTech

Singapore’s Respiree closes $11.6M Series A financing round led by We Venture Capital and ClavystBio

Respiree, a Singapore-based health tech company with artificial intelligence (AI) platforms, has announced the successful closing of a $11.6 million Series A financing round led by We Venture Capital and ClavystBio.

Foodpanda partners Heydoc Health to launch Malaysia’s first outpatient care for gig workers pilot program

Foodpanda Malaysia and digital health partner Heydoc Health have teamed up to launch Malaysia’s first outpatient care for gig workers pilot program.

Singapore’s Rebee Health raises investment from 1337 Ventures to expand digital physiotherapy solutions

Singapore-based health tech firm Rebee Health has raised investment from Malaysia-based venture capital firm 1337 Ventures to expand digital physiotherapy solutions.

Synapxe partners Google Cloud to boost AI capabilities and transform HealthTech in Singapore

Synapxe, a Singapore-based health tech firm, has signed a collaboration agreement with Google Cloud to enhance its data and artificial intelligence (AI) platforms, HEALIX and Tandem, leveraging Google Cloud’s interoperable, industry-leading data and AI platform services.

ClavystBio and A*STAR partner to grow MedTech ventures in Singapore

ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector research and development (R&D) agency, have signed a memorandum of understanding (MoU) to create and grow MedTech ventures in Singapore.

Quadria Capital closes oversubscribed $1B fund III to advance healthcare transformation across Asia

Quadria Capital, a Singapore-based premier healthcare-focused private equity firm, announced Monday the final close of its Fund III with $1.07 billion in total commitments, significantly exceeding its original $800 million target.

Temasek-backed SeaTown invests $89M in healthcare firm AddVita

Temasek-based investment firm SeaTown Holdings International announced Wednesday its investment via SeaTown Private Capital Master Fund (SeaTown PCap Fund) in AddVita, a Singapore headquartered healthcare and life sciences distribution company.

Singapore’s Nuevocor raises $45M Series B for Novel Cardiomyopathy therapy development

Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, has announced the successful completion of $45 million Series B financing.

Creador acquires minority stake in Vietnam’s pharmacy chains FPT Long Chau Investment JSC

Creador, a Malaysia-based private equity firm in South and Southeast Asia, has announced the acquisition of up to 13 percent in FPT Long Chau Investment JSC (Long Chau), one of Vietnam’s leading pharmacy chains.

Malaysia’s digital third-party administrator HealthMetrics launches in Indonesia

HealthMetrics, a Malaysia-based digital third-party administrator (TPA), announced the official launch of HealthMetrics Indonesia - uniting the longstanding expertise of Across Asia Assist Indonesia (AAA) with its advanced digital infrastructure to create a single, integrated digital TPA powerhouse poised to transform healthcare administration in Indonesia…